- Author:
Te BA
1
,
2
;
Kai-Hang SUN
1
,
2
;
Jing WANG
1
,
2
;
Ze-Ran WANG
1
,
2
;
Bo-Mo SANG
1
,
2
;
Hong-Kuan LI
1
,
2
;
Hao-Ran GUO
1
,
2
;
Xue YANG
1
,
2
;
Yu-Jie ZHENG
1
,
2
;
Xiao-Feng ZHAO
1
,
2
Author Information
- Publication Type:Journal Article
- Keywords: acupuncture; ischemic stroke; mesenchymal stem cells; stromal cell-derived factor-1α/CXC chemokine receptor 4 (SDF-1α/CXCR4) axis
- MeSH: Humans; Ischemic Stroke; Chemokine CXCL12; Acupuncture Therapy; Mesenchymal Stem Cells; Inflammation
- From: Chinese Acupuncture & Moxibustion 2023;43(6):691-696
- CountryChina
- Language:Chinese
- Abstract: The scientific basis of acupuncture on mesenchymal stem cells (MSCs) for treating ischemic stroke (IS) is discussed. MSCs transplantation has great potential for the treatment of tissue damage caused by early stage inflammatory cascade reactions of IS, but its actual transformation is limited by various factors. How to improve the homing efficiency of MSCs is the primary issue to enhance its efficacy. As such, the possible mechanisms of acupuncture and MSCs transplantation in inhibiting inflammatory cascade reactions induced by IS are explored by reviewing literature, and a hypothesis that acupuncture could promote the secretion of stromal cell-derived factor-1α (SDF-1α) from ischemic foci to regulate SDF-1α/CXC chemokine receptor 4 (CXCR4) axis, thereby improving the homing efficiency of MSCs transplantation, exerting its neuroprotective function, and improving the bed transformation ability, is proposed.